277 related articles for article (PubMed ID: 11078447)
1. Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism.
Suarez-Pinzon W; Korbutt GS; Power R; Hooton J; Rajotte RV; Rabinovitch A
Diabetes; 2000 Nov; 49(11):1810-8. PubMed ID: 11078447
[TBL] [Abstract][Full Text] [Related]
2. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
[TBL] [Abstract][Full Text] [Related]
3. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
Suarez-Pinzon W; Sorensen O; Bleackley RC; Elliott JF; Rajotte RV; Rabinovitch A
Diabetes; 1999 Jan; 48(1):21-8. PubMed ID: 9892218
[TBL] [Abstract][Full Text] [Related]
4. Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.
Luo X; Yang H; Kim IS; Saint-Hilaire F; Thomas DA; De BP; Ozkaynak E; Muthukumar T; Hancock WW; Crystal RG; Suthanthiran M
Transplantation; 2005 May; 79(9):1091-6. PubMed ID: 15880049
[TBL] [Abstract][Full Text] [Related]
5. Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice.
Korbutt GS; Suarez-Pinzon WL; Power RF; Rajotte RV; Rabinovitch A
Diabetologia; 2000 Apr; 43(4):474-80. PubMed ID: 10819241
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
Transplantation; 1997 Dec; 64(11):1525-31. PubMed ID: 9415551
[TBL] [Abstract][Full Text] [Related]
7. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
[TBL] [Abstract][Full Text] [Related]
8. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
9. Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells.
Dufour JM; Dass B; Halley KR; Korbutt GS; Dixon DE; Rajotte RV
Cell Transplant; 2008; 17(5):525-34. PubMed ID: 18714671
[TBL] [Abstract][Full Text] [Related]
10. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Redd S; Ginn S; Ross JM
Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice.
Suarez-Pinzon WL; Power RF; Rabinovitch A
Diabetologia; 2000 Sep; 43(9):1149-56. PubMed ID: 11043861
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
Rabinovitch A; Suarez-Pinzon WL; Shapiro AM; Rajotte RV; Power R
Diabetes; 2002 Mar; 51(3):638-45. PubMed ID: 11872661
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the immunomodulatory properties of Sertoli cells to enable xenotransplantation in type I diabetes.
Dufour JM; Rajotte RV; Korbutt GS; Emerich DF
Immunol Invest; 2003 Nov; 32(4):275-97. PubMed ID: 14603995
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
[TBL] [Abstract][Full Text] [Related]
16. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts.
Gysemans CA; Waer M; Valckx D; Laureys JM; Mihkalsky D; Bouillon R; Mathieu C
Diabetes; 2000 Dec; 49(12):1992-7. PubMed ID: 11117999
[TBL] [Abstract][Full Text] [Related]
17. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype.
King C; Davies J; Mueller R; Lee MS; Krahl T; Yeung B; O'Connor E; Sarvetnick N
Immunity; 1998 May; 8(5):601-13. PubMed ID: 9620681
[TBL] [Abstract][Full Text] [Related]
19. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice.
Augstein P; Heinke P; Salzsieder E; Berg S; Rettig R; Salzsieder C; Harrison LC
Endocrinology; 2004 Jun; 145(6):2747-52. PubMed ID: 15033908
[TBL] [Abstract][Full Text] [Related]
20. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
